Understanding the underlying causes of AMR and HCAI, identifying the best methods to improve antimicrobial use, their potential impact and their cost-effectiveness
The Unit is a partnership between Imperial College and UK Health Security Agency. It has been funded by NIHR for a further five-year term from 1 April 2020 and builds on an existing critical mass of research conducted between 01 April 2014 - 31 March 2020.
The Unit’s current partners are:
The National Institute for Health Research (NIHR) has funded the development of a number of Health Protection Research Units (HPRU) in key priority areas. These research units are collaborations between Universities, UK Health Security Agency (UK-HSA) and other partner organisations and aim to provide centres of excellence in multi-disciplinary health protection research.
The NIHR HPRU in Healthcare Associated Infections (HCAI) and Antimicrobial Resistance (AMR) at Imperial College London, started on 1 April 2014 and has now renewed five-year funding from 1 April 2020.
Our HPRU recognises the different skills required to address the threat of AMR and HCAIs, and it brings together researchers from a range of disciplines and professions (including doctors, engineers, epidemiologists, microbiolosts, pharmacists, behavioural scientists, economists, and nurses). Our approach to addressing HCAIs and AMR is via four complementary themes:
- Priority pathogens
- Precision prescribing
- Practice, design and engineering
- Population health and policy